Health ❯Healthcare ❯Patient Care

Treatment Options

AI-Assisted Treatment Cognitive Impairment Needle-Free Alternatives Innovative Therapies Chronic Itch Relief Personalized Medicine Alzheimer's Treatments Combination Therapies Rare Diseases Medication Management Survival Rates Biologic Therapies Miplyffa Therapies Combination Therapy Specialization Trends Low-Grade Serous Ovarian Cancer Hydration and Recovery Obesity Management Radiation Therapy Intravenous Therapy Therapeutic Approaches Alzheimer's Disease Attruby for ATTR-CM Chemotherapy Alternatives Home Care for Viral Infections Antidepressant Options Guillain-Barré Syndrome Management Guillain-Barré Syndrome Personal Management GLP-1 Medications

Daniel Barenboim Announces Parkinson’s Diagnosis at Age 82

FDA Approves First Nasal Spray for Treatment-Resistant Depression

Pfizer Ends Hemophilia Gene Therapy Partnership With Sangamo, Sending Stock Plummeting

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

NHS Introduces First-Ever Treatment for Rare Eye Cancer

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

New Radioactive Therapy Shrinks Glioblastoma Tumor by Half in NHS Trial

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

UCB and Biogen's Lupus Drug Shows Promising Phase 3 Results

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop

FDA Approves First Treatment for Niemann-Pick Disease Type C

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis